Clearing the Haze: What Do We Still Need to Learn About Electronic Nicotine Delivery Systems?
Important questions remain regarding the relative benefits versus risks of electronic nicotine delivery systems (ENDS). In light of these challenges, the authors propose key ENDS research priorities to address these gaps.Source: Cancer Prevention Research
Yale Study: Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
Greg Rhee, PhD, Assistant Professor Adjunct, is first author of a paper published in JAMA Network Open that examines the trends of buprenorphine use in emergency departments in the United States from 2002 (when it was approved) through 2017.Source: JAMA Network Open
WHRY Launches Studies on Endometrial Cancer, Addiction to Opioids, and Stroke
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
Evaluating Bystander Intervention Training to Address Patient Harassment at the Veterans Health Administration
Mark Relyea, PhD, Associate Research Scientist, is the lead author of a new study that evaluated implementation of a VA harassment awareness and bystander intervention training that teaches health care staff how to identify and intervene in the harassment of women veteran patients.Source: ScienceDirect
New Study by Yale Psychiatry Researchers Identifies How to Better Screen for Perpetrators of Intimate Partner Violence
Despite increasing implementation of health care-based screening for intimate partner violence (IPV) victimization, there is little focus and evidence-base to inform practice and policy for IPV perpetration. Yet patients and health care providers tend to agree on many elements of how to effectively screen for IPV perpetration, a new study by Yale Psychiatry researchers concludes.
Yale Study: Use of a Model Maturity Matrix to Build a Quality Improvement Infrastructure for Psychiatric Care
Luming Li, MD, Assistant Professor of Psychiatry, is senior author of a paper published in Psychiatric Services that proposes the use of a quality improvement maturity matrix to serve as both an implementation strategy and a self-assessment measure to strategically guide development of infrastructure to improve the safety and quality of behavioral health care.Source: Psychiatric Services
Further Guidance for Researchers
In follow-up to recent communications from President Salovey, Provost Strobel, and me, basic science chairs and directors convened today to discuss the meaning of critical or essential work in the laboratory setting. As the situation on-the-ground around COVID evolves, so must our definition of critical and essential functions in the laboratory.
Yale School of Medicine Maintains its High National Ranking in Federal Research Funding
The 2019 total, $451,476,354, continues the school’s position in the top ten among U.S. medical schools that it has maintained each year since 2001. YSM ranked first in funding for psychiatry and dermatology; third for public health/preventive medicine and emergency medicine; fifth for radiology; sixth for neurology and ob-gyn; seventh for neurosurgery; and ninth for biochemistry, genetics, and internal medicine.
Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Genome screen uncovers new targets for cancer immunotherapy
A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates to unleash the immune system’s ability to attack a variety of tumor types, Yale Cancer Center researchers report Aug. 22 in the journal Cell.
How do humans survive infections? Study pinpoints the role of a key hormone
To overcome an infection, the immune system has to both kill the invading virus or bacterium, and tolerate the inflammation triggered by the infection. In a new study, Yale researchers have figured out a key component of the second infection-fighting mechanism.